Medicine inhaler

Kang July 11, 2

Patent Grant D791931

U.S. patent number D791,931 [Application Number D/546,035] was granted by the patent office on 2017-07-11 for medicine inhaler. This patent grant is currently assigned to KOREA UNITED PHARM. INC.. The grantee listed for this patent is KOREA UNITED PHARM. INC.. Invention is credited to Won Ho Kang.


United States Patent D791,931
Kang July 11, 2017

Medicine inhaler

Claims

CLAIM I claim the ornamental design for a medicine inhaler, as shown and described.
Inventors: Kang; Won Ho (Seoul, KR)
Applicant:
Name City State Country Type

KOREA UNITED PHARM. INC.

Sejong-si

N/A

KR
Assignee: KOREA UNITED PHARM. INC. (Sejong-si, KR)
Appl. No.: D/546,035
Filed: November 18, 2015

Foreign Application Priority Data

May 20, 2015 [KR] 30-2015-0025606
Current U.S. Class: D24/110
Current International Class: 2902
Field of Search: ;D24/107-108,110-110.1,110.4-110.5,127,164 ;D29/108

References Cited [Referenced By]

U.S. Patent Documents
D342994 January 1994 Rand et al.
5590645 January 1997 Davies et al.
5860419 January 1999 Davies et al.
5873360 February 1999 Davies et al.
6032666 March 2000 Davies et al.
D641076 July 2011 Grunstad
D659236 May 2012 Bobjer
D667105 September 2012 Zuyderhoudt
D670374 November 2012 Bobjer
D684254 June 2013 Zuyderhoudt
D684684 June 2013 Grunstad
D693458 November 2013 Wright
D737425 August 2015 Wieczorek
D745660 December 2015 Gruntad
D755950 May 2016 Meliniotis
2005/0174216 August 2005 Lintell
2005/0177275 August 2005 Harvey
2007/0125372 June 2007 Chen
2010/0078021 April 2010 Thoe
2010/0078022 April 2010 Striebig
2014/0083422 March 2014 Arvidsson
Foreign Patent Documents
300134033 Dec 1992 KR
300134034 Dec 1992 KR
100210412 Jul 1999 KR

Other References

Trademark Register, Trademark Registration No, 0417344, Pubiication Date: Apr. 15, 1998, Current Owner: Glaxo Group Ltd., citing the above references. cited by applicant .
Korean Intellectual Property Office (KR) Trademark Gazette, Registration No. 40-1052334, Publication Date: May 13, 2014, Classification 10 (10th Edition), Applicant: Glaxo Group Ltd, citing the above references. cited by applicant.

Primary Examiner: Fox; Barbara
Assistant Examiner: Bekic; Lilyana
Attorney, Agent or Firm: Hauptman Ham, LLP

Description



FIG. 1 is a perspective view of a medicine inhaler showing the new design;

FIG. 2 is a perspective view thereof;

FIG. 3 is a front view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a right side view thereof;

FIG. 7 is a top view thereof; and,

FIG. 8 is a bottom view thereof.

The broken lines in the drawings illustrate portions of the medicine inhaler that form no part of the claimed design.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed